Karyopharm Therapeutics Inc.盘中异动临近收盘股价大跌5.54%

市场透视2025-11-06

北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价大幅下挫5.54%。截至发稿，该股报5.34美元/股，成交量3.8392万股，换手率0.23%，振幅5.75%。最近的财报数据显示，该股实现营业收入44.04百万美元，净利润-33.13百万美元，每股收益-3.82美元，毛利41.81百万美元，市盈率-0.37倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2581703588?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-06 04:50","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2581703588","market":"us","top_or_hot":-1,"title":"Karyopharm Therapeutics Inc.盘中异动 临近收盘股价大跌5.54%","media":"市场透视","content":"<div>\n<p>北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价大幅下挫5.54%。截至发稿，该股报5.34美元/股，成交量3.8392万股，换手率0.23%，振幅5.75%。最近的财报数据显示，该股实现营业收入44.04百万美元，净利润-33.13百万美元，每股收益-3.82美元，毛利41.81百万美元，市盈率-0.37倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Karyopharm Therapeutics Inc.盘中异动 临近收盘股价大跌5.54%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKaryopharm Therapeutics Inc.盘中异动 临近收盘股价大跌5.54%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-06 04:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价大幅下挫5.54%。截至发稿，该股报5.34美元/股，成交量3.8392万股，换手率0.23%，振幅5.75%。最近的财报数据显示，该股实现营业收入44.04百万美元，净利润-33.13百万美元，每股收益-3.82美元，毛利41.81百万美元，市盈率-0.37倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b","article_id":"2581703588","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110604503194f1a515&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581703588","pubTimestamp":1762375830,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.股票出现异动，股价大幅下挫5.54%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。消息层面，截至04时50分，《加皇资本市场维持Karyopharm Therapeutics买入评级，目标价19美元》资讯为影响Karyopharm Therapeutics Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","KPTI":"Karyopharm Therapeutics Inc.","BK4139":"生物科技","LENZ":"Therapeutics","BK4007":"制药"},"translate_title":"Karyopharm Therapeutics Inc. 's intraday movement plunged 5.54% near the close","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1.5,"KPTI":1.5},"content_text":"北京时间2025年11月06日04时50分，Karyopharm Therapeutics Inc.（KPTI.us）股票出现异动，股价大幅下挫5.54%。截至发稿，该股报5.34美元/股，成交量3.8392万股，换手率0.23%，振幅5.75%。最近的财报数据显示，该股实现营业收入44.04百万美元，净利润-33.13百万美元，每股收益-3.82美元，毛利41.81百万美元，市盈率-0.37倍。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Karyopharm Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Lunai Bioworks Inc.、Sonnet Biotherapeutics Holdings, Inc.涨幅较大，Lunai Bioworks Inc.、Immuron Limited、Metavia Inc.较为活跃，换手率分别为701.34%、89.57%、81.89%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 (To Pur Com)、Ethzilla Corporation C/Wts 06/11/2025(To Pur Com)、Lunai Bioworks Inc.，振幅分别为84.66%、75.37%、74.26%。Karyopharm Therapeutics Inc.公司简介：Karyopharm Therapeutics Inc 是一家商业阶段的制药公司，开创了新型癌症疗法，致力于发现、开发和商业化针对核输出的药物，以治疗癌症和其他疾病。XPOVIO (selinexor)在美国获批用于多种血液系统恶性肿瘤适应症，包括与Velcade(硼替佐米)和地塞米松联合用于至少接受过一种既往治疗后的多发性骨髓瘤成人患者的治疗，与地塞米松联合治疗患有严重预处理多发性骨髓瘤的成年患者，以及作为单一疗法用于复发或难治性弥漫性大B细胞淋巴瘤成人患者的治疗。该公司的收入来自美国。消息层面，截至04时50分，《加皇资本市场维持Karyopharm Therapeutics买入评级，目标价19美元》资讯为影响Karyopharm Therapeutics Inc.的重要信息。该信息摘要如下：加皇资本市场分析师Brian Abrahams维持买入评级，目标价19美元。根据TipRanks数据显示，该分析师近一年总胜率为47.1%，总平均回报率为2.8%。总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581703588","isCrawlerRequest":true}

Karyopharm Therapeutics Inc.盘中异动 临近收盘股价大跌5.54%

精彩评论

Karyopharm Therapeutics Inc.盘中异动临近收盘股价大跌5.54%